Nutra Pharma Corp

NEW
OTCPK:NPHC (USA)  
$ 0.00010 (0%) 11:38 AM EST
At Loss
Market Cap:
$ 716.00K
Enterprise V:
$ 13.06M
Volume:
20.00K
Avg Vol (2M):
249.35K
Trade In:
Volume:
20.00K
At Loss
Avg Vol (2M):
249.35K

Business Description

Description
Nutra Pharma Corp operates as a biopharmaceutical company with intellectual property for drugs that treat autoimmune disorders, viral diseases, and pain. It is focused on homeopathic and drug discovery research and clinical development, and has developed four homeopathic drugs for the relief of pain: Nyloxin and Nyloxin Extra Strength, Pet Pain-Away, Equine Pain-Away, and Luxury Feet. Additionally, the company has developed two drug candidates: RPI-78M, to treat neurological diseases and autoimmune diseases; and RPI-MN, to treat viral diseases, including HIV/AIDS and Herpes. Nutra Pharma produces, markets, and distributes its branded products both domestically and internationally.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset
-34.04
Debt-to-Equity
-0.58
Debt-to-EBITDA
-2.51
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-252.64
Distress
Grey
Safe
Beneish M-Score
-10.09
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
0.93
9-Day RSI
8.91
14-Day RSI
20.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.02
Quick Ratio
0.02
Days Inventory
48.35
Days Sales Outstanding
67.08
Days Payable
1969.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-0.3
Shareholder Yield %
-205.45

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
40.54
Operating Margin %
-631.66
Net Margin %
-2093.44
EBITDA Margin %
-1898.84
FCF Margin %
-405.4
OCF Margin %
-405.41
ROA %
-798.76
ROIC %
-14.23
3-Year ROIIC %
25.49
ROC (Joel Greenblatt) %
-12500
Years of Profitability over Past 10-Year
1
Name Current Vs Industry Vs History
PE Ratio without NRI
N/A
N/A
N/A
EV-to-EBIT
-2.63
EV-to-EBITDA
-2.64
EV-to-Revenue
50.42
EV-to-FCF
-12.44
Earnings Yield (Greenblatt) %
-38.02
FCF Yield %
-146.65

GF Valueâ„¢

Nutra Pharma Corp Filings

Filing Date Document Date Form
No Filing Data

Nutra Pharma Corp Stock Events

Financials Calendars
Event Date Price ($)
General meeting for 2025 2026-09-16 0.00 (+0.00%)
Second quarter earnings results for 2026 2026-08-19 0.00 (+0.00%)
First quarter earnings results for 2026 2026-05-29 0.00 (+0.00%)
Annual report for 2025 2026-05-20 0.00 (+0.00%)
Third quarter earnings results for 2025 2026-04-06 0.00 (+0.00%)
Second quarter earnings results for 2025 2026-03-25 0.00 (+0.00%)
First quarter earnings results for 2025 2026-03-11 0.00 (+0.00%)
Annual report for 2024 2026-02-17 0.00 (+0.00%)
Third quarter earnings results for 2024 2026-01-02 0.00 (+0.00%)
Second quarter earnings results for 2024 2025-12-23 0.00 (+0.00%)
Show
Entries

Guru Commentaries on OTCPK:NPHC

No fund manager commentary yet.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1